Is SNAP-8 FDA approved?
No. This profile records SNAP-8 as not FDA approved and for research use only.
MORE CONTEXT ›
Review the regulatory and source details on this page for the current context.
THE EXPRESSION SMOOTHER
Acetyl Octapeptide-3; Acetyl Glutamyl Heptapeptide-1
SNAP-8 is a cosmetic peptide that works like a topical, milder version of Botox. It disrupts the SNARE complex that enables muscle contraction, reducing the facial muscle movements that cause expression lines and wrinkles. Unlike Botox, it's applied topically and works gradually, offering a needle-free alternative for reducing crow's feet, forehead lines, and frown lines.
Not FDA approved · research use only
Reviewed by our clinical team
1 research sources
Aug 28, 2026
Dose and schedule recommendations shown below come from The Peptide App Clinical Team. Research links are provided so readers can inspect the supporting evidence directly. Review the sources.
No. This profile records SNAP-8 as not FDA approved and for research use only.
Review the regulatory and source details on this page for the current context.
Dose: 3-10% concentration in topical products, applied twice daily.
Schedule: daily. Cycle: Ongoing daily use. This is clinical-team guidance for reference and does not replace individualized instructions from a licensed clinician.
This guide links to 1 curated or current research sources.
Open the research section to inspect the source titles, publication details, study types, and available abstracts directly.
Competes with SNAP-25 to reduce muscle contraction signaling
Reduces acetylcholine release for softer expressions
Modulates neuropeptide release (substance P, CGRP)
Decreases depth of expression lines
The live research feed did not return papers for this page. The curated references below remain available for crawlable source context.